OBI Pharma, Inc.

NT$48.55As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4174Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (22.82%)
Div yield —
ROE (61.67%)
Biotechnology
Beta (5Y) (0.02)
PE TTM —
TSR TTM (2.51%)
Mkt cap NT$6.388B
ROIC (30.42%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$55
13.06%
(59.09%)
Hold 3|6|2|9|9
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.88
0.93
0.91
0.99
0.95%
3.62%
2.45%
16.04%
RevenueNT$M
384.1
405.1
406.5
405.1
10.29%
10.36%
10.34%
4.42%
Peers (US$192.9M)
Cap (US$)
PE
192.3M
—
184.3M
5.939x
Capital
TTM
5Y
10Y
Leveragex
3.946
0.343
0.309
EBIT/Intx
1.161
0.246
0.330
Own earn%
47.25
67.36
63.43
Sh yield%
34.89
28.01
32.68
Owners
Insiders/Inst%
13.50
21.63
Short interest%
2.07
SBC / revenue%
0.93
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
10–16
$1 testx
—
Incr. ROIC%
−2